Startup Spotlight: Istari Oncology enters agreement with FUJIFILM Diosynth Biotechnologies
Istari Oncology and FUJIFILM Diosynth Biotechnologies will work together, according to the terms of a new agreement.
Read More
Istari
Duke oncology startup expands immune-boosting tech built around polio vaccine
A Duke University spinout is expanding its trial of an immune-boosting technology that uses variations of the polio vaccine to treat patients with cancer. Here’s the latest.
Read More
Istari Oncology, now with FDA clearance for PVSRIPO, raises $43.4M
Istari Oncology received FDA clearance to move forward on a Phase 1/2 clinical trial to test a drug treatment that may help treat patients with cancer.
Read More
War on cancer: Duke spinout pursues revolutionary treatment using polio vaccine
An RTP biotech company has an extremely promising new cancer treatment with the potential to eliminate any solid tumor, even those otherwise treatment-resistant.
Read More
Biotech startup out of Duke achieves rare positive results in brain cancer treatment
A startup launched by Duke brain cancer scientists has achieved rare positive results in a treatment for the type of brain cancer killing Senator John McCain and that took the life of Senator Ted Kennedy.
Read More
